Association of CYP2C19 genotype with type 2 diabetes
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Abstract
Background: CYP2C19 is a major isoform of cytochrome P450 that metabolizes a number of commonly prescribed drugs such as omeprazole, diazepam, tolbutamide and propranolol. Its expression is regulated by the constitutive androstane receptor (CAR), involved in glucocorticoids synthesis. Since a number of crossliniks have been described for CYPs and some hormones, an association of CYP2C19 with type 2 diabetes is likely. Methods: Two groups were studied, 352 diagnosed with type 2 diabetes patients and 342 healthy volunteers form Mexico City. Both groups were tested for CYP2C19*2 and *3 alleles. We carried out an allelic discrimination using TaqMan assay for *2, and used FRET sensor and anchor probes for *3. Results: Ninety one percent of the subjects had the wild type allele, 9% have the *2 allele; no subject presented the *3 allele. The CYP2C19*2 allele is associated with type 2 diabetes (p = 0.012). Admixmap program was used to correct the admixture of this population and get the correlation. This was further confirmed in a linear model with a 67% power and by the method of Strom and Wienker for association on subjects within the mean range of Amerindian ancestry only (60%). Conclusion: Type 2 diabetes patients have significatly more *2 allele than healthy volunteers, more evident for the patients with the homocygous genotype.
- Chan, J., Donalson, L.M., Kushwaha, R.S., Ferdinan- dusse, S., VandeBerg, J.F. and VandeBerg, J.L. (2008) Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums. Metabolism, 57(5), 718-724.
- Bertilsson, L., Dahl, M.L., Dalen, P. and Al-Shurbaji, A. (2002) Molecular genetics of CYP2D6: Clinical rele- vance with focus on psychotropic drugs. British Journal of Clinical Pharmacology, 53(2), 111-122.
- Wedlund, P.J. (2000) The CYP2C19 enzyme polymer- phism. Pharmacology, 61(3), 174-183.
- Hamdy, S.I., Hiratsuka, M., Narahara, K., El-Enany, M., Moursi, N., Ahmed, M.S., et al. (2002) Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. British Journal of Clinical Pharmacology, 53(6), 596- 603.
- Bravo-Villalta, H.V., Yamamoto, K., Nakamura, K., Baya, A., Okada, Y. and Horiuchi, R. (2005) Genetic poly- morphism of CYP2C9 and CYP2C19 in a Bolivian population: An investigative and comparative study. European Journal of Clinical Pharmacology, 61(3), 179- 184.
- Isaza, C., Henao, J., Martinez, J.H., Arias, J.C. and Beltran, L. (2007) Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals. BMC Cli- nical Pharmacology, 7(1), 6.
- Jurima-Romet, M., Goldstein, J.A., LeBelle, M., Aubin, R.A., Foster, B.C., Walop, W., et al. (1996) CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population. Pharma- cogenetics, 6(4), 329-339.
- Lewis, D.F. (2003) Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xeno- biotics: A compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families. Current Medicinal Chemistry, 10(19), 1955-1972.
- Cavalli-Sforza, L.L., Menozzi, P. and Piazza, A. (1994) The history and geography of human genes. Princeton University Press, Princeton.
- Handschin, C., Podvinec, M. and Meyer, U.A. (2000) CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proceedings of National Academic Sciences of USA, 97(20), 10769-10774.
- Martinez-Marignac, V.L., Valladares, A., Cameron, E., Chan, A., Perera, A., Globus-Goldberg, R., et al. (2007) Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet, 120(6), 807-819.